AC Immune Ltd (ACIU) — Cash Flow Reinvestment Rate
AC Immune Ltd (ACIU) has a Cash Flow Reinvestment Rate of 0.66x as of December 2024, reinvesting $3.92 Million (capex $90.00K plus investments $-3.83 Million) from operating cash flow of $5.93 Million. Explore ACIU capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
AC Immune Ltd Cash Flow Reinvestment Rate (2015–2024)
Historical reinvestment intensity for AC Immune Ltd across 3 annual periods. Also explore ACIU current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for AC Immune Ltd (2015–2024)
Year-by-year capital reinvestment analysis for AC Immune Ltd. For live market cap and broader valuation context, see AC Immune Ltd (ACIU) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.61x | $105.87 Million | $65.84 Million | $576.00K | ▲ +29.1% |
| 2019 | 1.25x | $68.77 Million | $55.22 Million | $1.89 Million | ▲ +83.0% |
| 2015 | 0.68x | $29.99 Million | $44.08 Million | $244.00K | — |